HAVE THE COURTS TAKEN THE BITE OUT OF THE FTC WATCHDOG?

more+
less-

Have the Courts limited the role of the FTC when innovator pharmaceutical companies negotiate settlements with generic manufacturers over patent infringement suits brought under the Hatch-Waxman Act? Have recent decisions led to more reverse payment settlements? The article looks at recent decisions and the real impact on the types of settlements that are currently being negotiated. The article also reflects on how the FTC perceives these decisions on its ability to effectively review these settlements.

LOADING PDF: If there are any problems, click here to download the file.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Patricia Werschulz | Attorney Advertising

Written by:

more+
less-

Patricia Werschulz on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×